Skip to content

Article: Muscle Loss and Reduced Physical Performance in Emery–Dreifuss Muscular Dystrophy: Preclinical Findings

Muscle Loss and Reduced Physical Performance in Emery–Dreifuss Muscular Dystrophy: Preclinical Findings


Synopsis

Autosomal Emery–Dreifuss muscular dystrophy (EDMD) is caused by mutations in the lamin A/C gene (LMNA), which encodes nuclear envelope proteins. The disease typically causes muscle wasting and weakness, joint contractures, and heart problems, though muscle involvement varies. Previous studies with Lmna^H222P/H222P mice, a model for EDMD, showed altered signaling pathways in heart and muscle, and blocking these pathways improved heart function. This study found that these mice also have significant loss of lean muscle mass and impaired physical performance, including reduced VO2 peak and altered respiratory exchange ratio. These findings reveal decreased overall physical capacity in the model and provide a new way to evaluate future treatments for EDMD.

Journal

Human Molecular Genetics

Read more

Alzheimer's Disease

The Effects of NAD+ Boosting in Mitochondrial DNA Depletion Syndrome: Preclinical Findings

Synopsis Patients with mtDNA depletion syndrome 3 (MTDPS3) often die young from liver failure due to severely reduced mitochondrial DNA. Research into treatments has been difficult because MTDPS3 ...

Read more
Mitochondrial Health

CD38 Inhibitor Reverses Age-Related NAD+ Decline and Metabolic Dysfunction: Preclinical Findings

Synopsis Aging is characterized by the development of metabolic dysfunction and frailty. Recent studies show that a reduction in nicotinamide adenine dinucleotide (NAD+) is a key factor for the de...

Read more